Actively Recruiting
Evaluating the Efficacy and Safety of Pitolisant for Excessive Daytime Sleepiness in Patients With Prader-Willi Syndrome With an Optional Open-Label Extension
Led by Harmony Biosciences Management, Inc. · Updated on 2026-08-25
134
Participants Needed
57
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of pitolisant on excessive daytime sleepiness EDS in patients aged 6 years and older with Prader-Willi syndrome. This Phase 3, randomized, double-blind, placebo-controlled global study aims to assess both the efficacy and safety of pitolisant. The study also investigates how pitolisant impacts irritable and disruptive behaviors, hyperphagia, and other behavioral issues such as social withdrawal, stereotypic behavior, hyperactivity, noncompliance, and inappropriate speech. The study includes an up to 45-day screening and baseline period followed by a double-blind treatment phase where participants are randomly assigned to receive either pitolisant tablets or matching placebo tablets once daily in the morning upon waking. This treatment period includes in-person visits on Days 29, 57, and 77. Afterward, participants may enter an optional open-label extension period receiving pitolisant, with visits on Days 113, 260, and 441. Follow-up visits occur 15 and 30 days after the last dose during both treatment periods. Participants will undergo various assessments including patient-reported measures of sleep-related impairment and caregiver and clinical impressions of sleepiness and behavior at baseline and the end of the double-blind phase. Behavioral scales like the Aberrant Behavior Checklist and Hyperphagia Questionnaire are used to evaluate changes. Safety is monitored by tracking adverse events throughout the study. The total duration of participation may extend beyond one year for those joining the extension period.
CONDITIONS
Brief Title
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Research Team
A
Ann Adee
L
Linnea Ryan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here